Healthcare executives must monitor the pharmaceutical supply chain to combat counterfeit drugs, as overdose deaths related to fake pills have been rising. The Drug Supply Chain Security Act (DSCSA) aims to address this issue by establishing a track-and-trace system for prescription drugs. Gee Mathen, director at Texas Children’s Hospital, will discuss the impact of DSCSA at the HIMSS Global Conference. Counterfeit drugs are a significant issue in healthcare, posing risks to patient safety. DSCSA enhances traceability, prevents distribution of counterfeit drugs, and improves drug recall processes. Attendees will learn about the importance of technology in preventing counterfeit medications at Mathen’s session.
Source link
HIMSS24 preview: Combating counterfeit drugs in a health system
